These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38351451)

  • 1. Lipofection-Based Delivery of CRISPR/Cas9 Ribonucleoprotein for Gene Editing in Male Germline Stem Cells.
    Obermeier M; Rogiers V; Vanhaecke T; Baert Y
    Methods Mol Biol; 2024; 2770():123-134. PubMed ID: 38351451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells.
    Liu W; Rudis MR; Cheplick MH; Millwood RJ; Yang JP; Ondzighi-Assoume CA; Montgomery GA; Burris KP; Mazarei M; Chesnut JD; Stewart CN
    Plant Cell Rep; 2020 Feb; 39(2):245-257. PubMed ID: 31728703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Multi-Allelic Genome Editing of Primary Cell Cultures via CRISPR-Cas9 Ribonucleoprotein Nucleofection.
    Hoellerbauer P; Kufeld M; Paddison PJ
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e126. PubMed ID: 32833346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
    Chen S; Lee B; Lee AY; Modzelewski AJ; He L
    J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipofection of Non-integrative CRISPR/Cas9 Ribonucleoproteins in Male Germline Stem Cells: A Simple and Effective Knockout Tool for Germline Genome Engineering.
    Obermeier M; Vadolas J; Verhulst S; Goossens E; Baert Y
    Front Cell Dev Biol; 2022; 10():891173. PubMed ID: 35774227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells.
    Xu H; Kita Y; Bang U; Gee P; Hotta A
    STAR Protoc; 2021 Dec; 2(4):100965. PubMed ID: 34825222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Simple and Efficient Procedure for Developing Mouse Germline Stem Cell Lines with Gene Knock-in via CRISPR/Cas9 Technology.
    Wang Y; Hu S; Han C
    Curr Protoc; 2024 Sep; 4(9):e70002. PubMed ID: 39264143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Editing in Chlamydomonas reinhardtii Using Cas9-gRNA Ribonucleoprotein Complex: A Step-by-Step Guide.
    Dhokane D; Kancharla N; Savarimuthu A; Bhadra B; Bandyopadhyay A; Dasgupta S
    Methods Mol Biol; 2023; 2653():207-217. PubMed ID: 36995629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
    Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
    Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical Modification of Guide RNAs for Improved CRISPR Activity in CD34+ Human Hematopoietic Stem and Progenitor Cells.
    Shapiro J; Tovin A; Iancu O; Allen D; Hendel A
    Methods Mol Biol; 2021; 2162():37-48. PubMed ID: 32926376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for genomic editing in human resting primary NK cells and NK-92 cells via CRISPR-Cas9 ribonucleoproteins.
    Verhezen T; Lau HW; Van Audenaerde J; Wouters A; Smits E; De Waele J
    STAR Protoc; 2024 Sep; 5(3):103123. PubMed ID: 38935511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements.
    Lattanzi A; Meneghini V; Pavani G; Amor F; Ramadier S; Felix T; Antoniani C; Masson C; Alibeu O; Lee C; Porteus MH; Bao G; Amendola M; Mavilio F; Miccio A
    Mol Ther; 2019 Jan; 27(1):137-150. PubMed ID: 30424953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutagenesis of Nasonia vitripennis through ovarian delivery of CRISPR-Cas9 ribonucleoprotein.
    Chaverra-Rodriguez D; Dalla Benetta E; Heu CC; Rasgon JL; Ferree PM; Akbari OS
    Insect Mol Biol; 2020 Dec; 29(6):569-577. PubMed ID: 32715554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing.
    Dubey S; Chen Z; Jiang YJ; Talis A; Molotkov A; Ali A; Mintz A; Momen-Heravi F
    Theranostics; 2024; 14(7):2777-2793. PubMed ID: 38773978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribonucleoproteins Mediated Efficient In Vivo Gene Editing in Skin Stem Cells.
    Wu W; Chen T
    Methods Mol Biol; 2019; 1879():75-86. PubMed ID: 30426459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome Editing Using Cas9-gRNA Ribonucleoprotein in Human Pluripotent Stem Cells for Disease Modeling.
    Benetó N; Grinberg D; Vilageliu L; Canals I
    Methods Mol Biol; 2022; 2549():409-425. PubMed ID: 33755903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing
    Hamada T; Yokoyama S; Akahane T; Matsuo K; Tanimoto A
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 19. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.
    Bloomer H; Khirallah J; Li Y; Xu Q
    Adv Drug Deliv Rev; 2022 Feb; 181():114087. PubMed ID: 34942274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescent labeling of CRISPR/Cas9 RNP for gene knockout in HSPCs and iPSCs reveals an essential role for GADD45b in stress response.
    Nasri M; Mir P; Dannenmann B; Amend D; Skroblyn T; Xu Y; Schulze-Osthoff K; Klimiankou M; Welte K; Skokowa J
    Blood Adv; 2019 Jan; 3(1):63-71. PubMed ID: 30622144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.